Novacyt Statistics
Total Valuation
Novacyt has a market cap or net worth of EUR 31.59 million. The enterprise value is 16.70 million.
| Market Cap | 31.59M |
| Enterprise Value | 16.70M |
Important Dates
The last earnings date was Wednesday, September 24, 2025.
| Earnings Date | Sep 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Novacyt has 70.52 million shares outstanding.
| Current Share Class | 70.52M |
| Shares Outstanding | 70.52M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 0.02% |
| Float | 70.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.47 |
| EV / Sales | 0.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.06 |
Financial Position
The company has a current ratio of 5.03, with a Debt / Equity ratio of 0.27.
| Current Ratio | 5.03 |
| Quick Ratio | 4.34 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.58 |
| Interest Coverage | -22.70 |
Financial Efficiency
Return on equity (ROE) is -51.22% and return on invested capital (ROIC) is -13.31%.
| Return on Equity (ROE) | -51.22% |
| Return on Assets (ROA) | -11.10% |
| Return on Invested Capital (ROIC) | -13.31% |
| Return on Capital Employed (ROCE) | -25.64% |
| Revenue Per Employee | 96,967 |
| Profits Per Employee | -151,563 |
| Employee Count | 234 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.75 |
Taxes
| Income Tax | -909,947 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.68% in the last 52 weeks. The beta is 1.11, so Novacyt's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -29.68% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 39.37 |
| Average Volume (20 Days) | 173,093 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novacyt had revenue of EUR 22.69 million and -35.47 million in losses. Loss per share was -0.51.
| Revenue | 22.69M |
| Gross Profit | 13.09M |
| Operating Income | -16.82M |
| Pretax Income | -34.15M |
| Net Income | -35.47M |
| EBITDA | -9.80M |
| EBIT | -16.82M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 27.67 million in cash and 12.77 million in debt, giving a net cash position of 14.90 million or 0.21 per share.
| Cash & Cash Equivalents | 27.67M |
| Total Debt | 12.77M |
| Net Cash | 14.90M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 47.64M |
| Book Value Per Share | 0.67 |
| Working Capital | 31.49M |
Cash Flow
In the last 12 months, operating cash flow was -7.24 million and capital expenditures -844,617, giving a free cash flow of -8.09 million.
| Operating Cash Flow | -7.24M |
| Capital Expenditures | -844,617 |
| Free Cash Flow | -8.09M |
| FCF Per Share | -0.11 |
Margins
Gross margin is 57.70%, with operating and profit margins of -74.11% and -156.30%.
| Gross Margin | 57.70% |
| Operating Margin | -74.11% |
| Pretax Margin | -150.49% |
| Profit Margin | -156.30% |
| EBITDA Margin | -43.19% |
| EBIT Margin | -74.11% |
| FCF Margin | n/a |
Dividends & Yields
Novacyt does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -112.26% |
| FCF Yield | -25.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novacyt has an Altman Z-Score of 0.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.68 |
| Piotroski F-Score | 2 |